Scientists are warning that the world could be in for an "antibiotic apocalypse", with a rise in drug-resistant superbugs killing an estimated 10 million people every year by 2050.
Science reporter Jamie Morton discusses the issue with one of New Zealand's best known microbiologists, Dr Siouxsie Wiles of the University of Auckland.
Q. What has prompted these fresh concerns and are the fears real?
A. The fears are definitely real, and the latest wave of media stories are because Lord Jim O'Neill just published his report on the topic, which was commissioned by the UK Prime Minister David Cameron.
We've also just had a report of the first US case of a person infected with a bacteria resistant to colistin, an old antibiotic with nasty side effects that is now only used as a last resort.
While the fear is that we will soon be living in a world with no effective antibiotics, in reality some patients are already living in that world, infected with untreatable resistant superbugs.
Q. We've also seen Lord O'Neill call for bans on the widespread use of antibiotics on animals. What's the connection here?
A. For his report, Lord O'Neill was tasked with coming up with some concrete actions to tackle the issue of antibiotic resistance internationally.
Antibiotics have been widely used agriculturally in some countries for two main reasons: as growth promoters - to speed up the time it takes to get the meat to market - and to prevent infections, which is important when animals are factory farmed.
The problem with using antibiotics in this way is that antibiotic-resistant superbugs that develop on farms, don't stay there.
And because people can often carry antibiotic-resistant superbugs without them causing disease, these superbugs can easily move from country to country.
They just hitch a ride on a plane up someone's nose, or in their bowels.
So even if we don't use antibiotics in this way, because other countries do, we are all at risk.
Q. There have been recommendations that pharmaceutical companies should get billion-dollar rewards for developing effective new drugs. What else do you feel needs to happen to meet the threat?
A. We definitely need more government and philanthropic support for the scientists around the world doing research into infectious diseases and antibiotic discovery.
This fundamental research is what enables the pharmaceutical companies to develop new treatments, but has been underfunded worldwide for many years.
You certainly don't see people running marathons to raise money for food poisoning or pneumonia.
Knowing the huge threat we face from antibiotic-resistant superbugs, coupled with the fact that New Zealand's rate of many infectious diseases are higher than countries like the UK, USA and Australia and are rising, I was astonished when infectious diseases were specifically excluded from the three multi-million dollar health-related National Science Challenges.
It's crucial that some of the new funds for health research recently announced by the government be dedicated to tackle antibiotic resistance.